Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 23, 1998

View Archived Issues

Biovector Planning IPO For 'At Least' FFr200M

Enzyme Structure Reveals Tumor Suppressor Function

Cerebrus, Lilly Team Up To Treat Chemo Emesis

Novartis Scientists Form Company To Target CNS

ExonHit, Rhone-Poulenc Target Tumor Suppressors

Irish Biotech Starving For Cash, Leaders Say

Cortecs Trims Spending, Denies Financing Rumors

Vanguard To Drop Drugs After Phase II Studies

Limagrain Forms Spin-Off; Investor Talks Under Way

EU Patents Directive Becoming A Reality